208 related articles for article (PubMed ID: 33489435)
1. A systematic evidence-based review of treatments for primary hyperhidrosis.
Stuart ME; Strite SA; Gillard KK
J Drug Assess; 2020 Dec; 10(1):35-50. PubMed ID: 33489435
[TBL] [Abstract][Full Text] [Related]
2. Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis.
Wade R; Rice S; Llewellyn A; Moloney E; Jones-Diette J; Stoniute J; Wright K; Layton AM; Levell NJ; Stansby G; Craig D; Woolacott N
Health Technol Assess; 2017 Dec; 21(80):1-280. PubMed ID: 29271741
[TBL] [Abstract][Full Text] [Related]
3. Interventional management of hyperhidrosis in secondary care: a systematic review.
Wade R; Llewellyn A; Jones-Diette J; Wright K; Rice S; Layton AM; Levell NJ; Craig D; Woolacott N
Br J Dermatol; 2018 Sep; 179(3):599-608. PubMed ID: 29573391
[TBL] [Abstract][Full Text] [Related]
4. A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
Glaser DA; Hebert AA; Nast A; Werschler WP; Green L; Mamelok RD; Quiring J; Drew J; Pariser DM
Am J Clin Dermatol; 2019 Aug; 20(4):593-604. PubMed ID: 31111409
[TBL] [Abstract][Full Text] [Related]
5. Topical Treatment of Primary Focal Hyperhidrosis, Part 1.
Zur E
Int J Pharm Compd; 2019; 23(1):23-31. PubMed ID: 30668532
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
7. Progress and lack of progress in hyperhidrosis research 2015-2020. A concise systematic review.
Kristensen JK; Nielsen C
Int J Dermatol; 2022 Feb; 61(2):148-157. PubMed ID: 34080686
[TBL] [Abstract][Full Text] [Related]
8. Open-Label Cohort Study to Evaluate Efficacy and Safety of Application of Glycopyrronium Cloth, 2.4% for Palmar Hyperhidrosis.
Pariser D; Rivera E; Benedict D
J Drugs Dermatol; 2022 May; 21(5):488-495. PubMed ID: 35533035
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for hyperhidrosis.
Walling HW; Swick BL
Am J Clin Dermatol; 2011 Oct; 12(5):285-95. PubMed ID: 21714579
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
Hebert AA; Glaser DA; Green L; Hull C; Cather J; Drew J; Gopalan R; Pariser DM
Pediatr Dermatol; 2020 May; 37(3):490-497. PubMed ID: 32147881
[TBL] [Abstract][Full Text] [Related]
12. Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
Nwannunu CE; Limmer AL; Coleman K; Shah R; Patel RR; Mui UN; Tyring SK
Skin Therapy Lett; 2019 Mar; 24(2):1-3. PubMed ID: 30970203
[TBL] [Abstract][Full Text] [Related]
13. Injectable botulinum toxin as a treatment for plantar hyperhidrosis: a case study.
Vlahovic TC; Dunn SP; Blau JC; Gauthier C
J Am Podiatr Med Assoc; 2008; 98(2):156-9. PubMed ID: 18347128
[TBL] [Abstract][Full Text] [Related]
14. Laser treatment of primary axillary hyperhidrosis: a review of the literature.
Cervantes J; Perper M; Eber AE; Fertig RM; Tsatalis JP; Nouri K
Lasers Med Sci; 2018 Apr; 33(3):675-681. PubMed ID: 29322402
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
Heckmann M; Ceballos-Baumann AO; Plewig G;
N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
[TBL] [Abstract][Full Text] [Related]
16. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
Karamfilov T; Konrad H; Karte K; Wollina U
Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
[TBL] [Abstract][Full Text] [Related]
17. Comparison of microwave ablation, botulinum toxin injection, and liposuction-curettage in the treatment of axillary hyperhidrosis: A systematic review.
Nasr MW; Jabbour SF; Haber RN; Kechichian EG; El Hachem L
J Cosmet Laser Ther; 2017 Feb; 19(1):36-42. PubMed ID: 27782761
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis.
Bloudek LM; Gillard KK; Nguyen VB; Klein SZ
J Med Econ; 2021; 24(1):29-37. PubMed ID: 33256494
[TBL] [Abstract][Full Text] [Related]
19. Treatments for excessive armpit sweating.
Drug Ther Bull; 2005 Oct; 43(10):77-80. PubMed ID: 16240957
[TBL] [Abstract][Full Text] [Related]
20. Experience with botulinum toxin therapy for axillary hyperhidrosis and comparison to modelled data for endoscopic thoracic sympathectomy - A quality of life and cost effectiveness analysis.
Gibbons JP; Nugent E; O'Donohoe N; Maher B; Egan B; Feeley M; Tierney S
Surgeon; 2016 Oct; 14(5):260-4. PubMed ID: 26071930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
